Stockscreener 앱 받기
3.59
1.64%
-0.06
전일 마감가:
$3.65
열려 있는:
$3.62
하루 거래량:
35,956
Relative Volume:
0.22
시가총액:
$15.22M
수익:
-
순이익/손실:
$-37.75M
주가수익비율:
-1.1046
EPS:
-3.25
순현금흐름:
$-30.91M
1주 성능:
+16.56%
1개월 성능:
+12.89%
6개월 성능:
-28.77%
1년 성능:
+1,382%
1일 변동 폭
$3.53
$3.6905
1주일 범위
$3.39
$4.10
52주 변동 폭
$0.23
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
명칭
Cellectar Biosciences Inc
전화
(608) 441-8120
주소
100 CAMPUS DRIVE, FLORHAM PARK, NJ
CLRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
3.59 | 15.48M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 재개 | Ladenburg Thalmann | Buy |
| 2020-07-01 | 개시 | Oppenheimer | Outperform |
| 2020-01-21 | 재개 | ROTH Capital | Buy |
| 2019-09-13 | 개시 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc 주식(CLRB)의 최신 뉴스
Fundamentals Check: How volatile is Cellectar Biosciences Inc stockWeekly Gains Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Ideas Watch: How cyclical is Cellectar Biosciences Incs revenue streamWeekly Stock Analysis & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Technicals: Does Cellectar Biosciences Inc have a sustainable dividendQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference - marketscreener.com
Cellectar Advances CLR 125 Into Early Breast Cancer Trial, Adding Depth to Its Radiotherapy Pipeline - TipRanks
Cellectar Biosciences to highlight strategic initiatives for 2026 - marketscreener.com
Cellectar Biosciences Outlines 2026 Strategic Plan and Regulatory Milestones for Iopofosine I 131 and CLR 125 at Biotech Showcase - Quiver Quantitative
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase ... - Bluefield Daily Telegraph
CLRBCellectar Biosciences Inc Latest Stock News & Market Updates - Stock Titan
HOKA Comfort Guide: Is Cellectar Biosciences Inc. stock dividend yield sustainableWide Width Options & support options for steady strides - Улправда
How Cellectar Biosciences Inc. stock performs in rate cut cyclesWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - Улправда
Sentiment Review: What catalysts could drive Cellectar Biosciences Inc stock higherPortfolio Profit Report & Low Risk Entry Point Guides - Bộ Nội Vụ
ABTBiotech Stocks Forge Ahead With Confidence on This Week's Healthy Biotech Rally - ADVFN
What catalysts could drive Cellectar Biosciences Inc. stock higherJuly 2025 Catalysts & Weekly Breakout Watchlists - Улправда
Why retail investors favor Cellectar Biosciences Inc. stockStop Loss & Real-Time Buy Signal Notifications - Улправда
Momentum Shift: Will Cellectar Biosciences Inc. stock outperform value stocksMarket Performance Recap & Weekly High Conviction Trade Ideas - Улправда
Published on: 2026-01-09 06:04:32 - Улправда
Is Cellectar Biosciences Inc. stock ready for breakoutForecast Cut & High Yield Stock Recommendations - Улправда
Trend Report: What catalysts could drive Cellectar Biosciences Inc. stock higherWeekly Market Summary & Fast Entry Momentum Trade Alerts - Улправда
Bond Watch: Why retail investors favor Cellectar Biosciences Inc. stock2025 Volume Leaders & Weekly Momentum Stock Picks - Улправда
Is Cellectar Biosciences Inc. stock a buy before product launchesWeekly Loss Report & AI Forecast Swing Trade Picks - Улправда
Is Cellectar Biosciences Inc. stock attractive for retirement portfoliosJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда
Will Cellectar Biosciences Inc. stock beat EPS estimatesJuly 2025 Sector Moves & Community Verified Watchlist Alerts - Улправда
Why Cellectar Biosciences Inc. stock could rally in 2025Earnings Per Share Trends & Affordable Market Strategies - Улправда
Trade Report: Why Rezolve AI PLC stock appeals to dividend seekersWeekly Trading Summary & Fast Momentum Entry Tips - moha.gov.vn
What drives Cellectar Biosciences Inc stock priceHealthcare Stock Analysis & Affordable Growth Trading - earlytimes.in
Targets Report: Why retail investors favor Cellectar Biosciences Inc stockMarket Growth Review & Accurate Entry/Exit Alerts - moha.gov.vn
Layoff Watch: Will Cellectar Biosciences Inc stock outperform value stocksBond Market & Community Verified Trade Signals - Bộ Nội Vụ
Can Ahimsa Industries Limited Regain Momentum After BreakdownMarket Rumors and News & Affordable Stock Market Tips - earlytimes.in
Will Cellectar Biosciences Inc. stock reach Wall Street targets2025 Investor Takeaways & Real-Time Volume Spike Alerts - Улправда
How Cellectar Biosciences Inc. (NV4) stock reacts to weak economyJuly 2025 WrapUp & Smart Allocation Stock Reports - Bölüm Sonu Canavarı
Will Cellectar Biosciences Inc. stock benefit from sector rotation2025 Stock Rankings & Low Volatility Stock Suggestions - Улправда
Why Cellectar Biosciences Inc. stock remains undervaluedJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Aug Swings: Will Cellectar Biosciences Inc. stock reach Wall Street targets2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
How Cellectar Biosciences Inc. stock trades before earningsJuly 2025 Volume & Low Risk Entry Point Tips - Улправда
Should I buy Cellectar Biosciences Inc. (NV4) stock before earnings seasonJuly 2025 Update & Real-Time Market Trend Scan - DonanımHaber
What MACD trends signal for Cellectar Biosciences Inc. (NV4) stock2025 Short Interest & Verified Momentum Stock Alerts - Улправда
Bond Watch: Why Cellectar Biosciences Inc. stock could rally in 2025July 2025 Setups & Momentum Based Trading Ideas - Улправда
Cellectar Biosciences announces supply agreement with Ionetix - MSN
Cellectar Biosciences, Inc. (CLRB) director John Neis reports stock sale - Stock Titan
Cellectar secures multi-year supply of alpha-emitting radioisotopes By Investing.com - Investing.com Australia
Cellectar Biosciences : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Cellectar Biosciences announces strategic supply agreement with Ionetix - marketscreener.com
Cellectar Biosciences (CLRB) Secures Supply Agreement for Radioi - GuruFocus
Cellectar secures multi-year supply of alpha-emitting radioisotopes - Investing.com
Cellectar Biosciences Announces Multi-Year Supply Agreement with Ionetix for Alpha-Emitting Radioisotopes - Quiver Quantitative
Cellectar Biosciences IncAnnounces Multi-Y - 富途牛牛
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies - GlobeNewswire
Cellectar Biosciences Earnings Notes - Trefis
MACD Signal: How Cellectar Biosciences Inc NV4 stock performs in easing cyclesRate Hike & Smart Money Movement Tracker - moha.gov.vn
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Companies in the Race | DelveInsight - The Globe and Mail
Cellectar Biosciences Inc (CLRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cellectar Biosciences Inc 주식 (CLRB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CARUSO JAMES V | Chief Executive Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
11,638 |
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
4.73%
0.92%
자본화:
|
볼륨(24시간):